Add to ORKGProvided are methods for using bis-quaternary ammonium compounds to treat inflammatory pain, neuropathic pain and nociceptive pain
Neuropathic pain is known to be pain with nerve involvement. The intensity of which depends on the s...
Neuropathic pain (NP) is a chronic, debilitating symptomatology of lesions/injuries of the central a...
Provided are tetrakis-quaternary ammonium compounds which are modulators of nicotinic acetylcholine ...
Provided are methods for using his-quaternary ammonium compounds to treat inflammatory pain, neuropa...
Provided are tris-quatemary ammonium compounds which are modulators of nociception and pain
Neuropathic pain is pain arising from nerve damage to the conductive pathways of pain (ranging from ...
Provided are bis-quaternary ammonium compounds which are modulators of nicotinic acetylcholine recep...
Neuropathic pain (NP) is a medical condition induced by diseases or lesions in the primary or inner ...
Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral ...
Provided are monoquaternary ammonium compounds which are modulators of nicotinic acetylcholine recep...
Neuropathic pain can result from injury to, or disease of the nervous system. It is notoriously diff...
Approximately 7–10% of the general population and 30% of cancer patients suffer from neuropathicpain...
The present disclosure is directed to the use of fusogenic compounds such as polyethylene glycol (PE...
Provided are bis-quaternary ammonium compounds which are modulators of nicotinic acetylcholine recep...
The present invention relates generally to the field of inflammatory diseases of the peripheral nerv...
Neuropathic pain is known to be pain with nerve involvement. The intensity of which depends on the s...
Neuropathic pain (NP) is a chronic, debilitating symptomatology of lesions/injuries of the central a...
Provided are tetrakis-quaternary ammonium compounds which are modulators of nicotinic acetylcholine ...
Provided are methods for using his-quaternary ammonium compounds to treat inflammatory pain, neuropa...
Provided are tris-quatemary ammonium compounds which are modulators of nociception and pain
Neuropathic pain is pain arising from nerve damage to the conductive pathways of pain (ranging from ...
Provided are bis-quaternary ammonium compounds which are modulators of nicotinic acetylcholine recep...
Neuropathic pain (NP) is a medical condition induced by diseases or lesions in the primary or inner ...
Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral ...
Provided are monoquaternary ammonium compounds which are modulators of nicotinic acetylcholine recep...
Neuropathic pain can result from injury to, or disease of the nervous system. It is notoriously diff...
Approximately 7–10% of the general population and 30% of cancer patients suffer from neuropathicpain...
The present disclosure is directed to the use of fusogenic compounds such as polyethylene glycol (PE...
Provided are bis-quaternary ammonium compounds which are modulators of nicotinic acetylcholine recep...
The present invention relates generally to the field of inflammatory diseases of the peripheral nerv...
Neuropathic pain is known to be pain with nerve involvement. The intensity of which depends on the s...
Neuropathic pain (NP) is a chronic, debilitating symptomatology of lesions/injuries of the central a...
Provided are tetrakis-quaternary ammonium compounds which are modulators of nicotinic acetylcholine ...